Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,819,263
  • Shares Outstanding, K 47,640
  • Annual Sales, $ 1,681 M
  • Annual Income, $ 154,770 K
  • 36-Month Beta 1.03
  • Price/Sales 2.86
  • Price/Cash Flow 13.73
  • Price/Book 5.48

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.07 +3.15%
on 07/12/17
102.32 -1.13%
on 06/29/17
+1.70 (+1.71%)
since 06/21/17
3-Month
86.66 +16.73%
on 04/25/17
102.32 -1.13%
on 06/29/17
+12.33 (+13.88%)
since 04/21/17
52-Week
67.20 +50.54%
on 11/03/16
102.32 -1.13%
on 06/29/17
+15.15 (+17.61%)
since 07/21/16

Most Recent Stories

More News
Charles River La Shares Up 32.6% Since SmarTrend's Buy Recommendation (CRL)

SmarTrend identified an Uptrend for Charles River La (NYSE:CRL) on December 14th, 2016 at $76.09. In approximately 7 months, Charles River La has returned 32.63% as of today's recent price of $100.92....

CRL : 101.16 (+0.06%)
Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2017 financial results on Wednesday, August 9th, before the market opens. A conference call has been...

CRL : 101.16 (+0.06%)
Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors

Charles River Laboratories International, Inc. (NYSE:CRL) today announced the appointment of Dr. Martin Mackay, Executive Vice President, Alexion Pharmaceuticals Inc., to its Board of Directors....

CRL : 101.16 (+0.06%)
Carl Data Announces New CFO Alastair Brownlow

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 27, 2017) - Carl Data Solutions Inc. (CSE:CRL)(CSE:CRL.CN)(CNSX:CRL)(FRANKFURT:7C5)(OTC PINK:CDTAF) ("Carl" or the "Company"), a developer of Big-Data-as-a-Service...

CRL.CN : 0.300 (+1.69%)
CDTAF : 0.2501 (+2.50%)
CRL : 101.16 (+0.06%)
Carl Data Announces New CFO Alastair Brownlow

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 27, 2017) - Carl Data Solutions Inc. (CSE:CRL)(CSE:CRL.CN)(CNSX:CRL)(FRANKFURT:7C5)(OTC PINK:CDTAF) ("Carl" or the "Company"), a developer of Big-Data-as-a-Service...

CRL.CN : 0.300 (+1.69%)
CDTAF : 0.2501 (+2.50%)
CRL : 101.16 (+0.06%)
Pharmaceutical Contract Manufacturing & Contract Research Market to Reach $238 Billion by 2025 - Analysis By Services, CRO & Segment

Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing & Contract Research Market, 2014 - 2025" report to their offering. The global pharmaceutical contract manufacturing/contract...

VRX.TO : 22.00 (-0.59%)
WST : 93.00 (-0.51%)
ABBV : 74.63 (+0.84%)
CRL : 101.16 (+0.06%)
AMRI : 21.70 (unch)
PFE : 33.48 (-0.18%)
Shares of CRL Up 30.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on December 14th, 2016 at $76.09. In approximately 6 months, Charles River Laboratories has returned 30.25% as of today's recent...

CRL : 101.16 (+0.06%)
Charles River Laboratories Up 23.4% Since SmarTrend Uptrend Call (CRL)

SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on December 14th, 2016 at $76.09. In approximately 6 months, Charles River Laboratories has returned 23.45% as of today's recent...

CRL : 101.16 (+0.06%)
Charles River Laboratories Up 23.4% Since SmarTrend Uptrend Call (CRL)

SmarTrend identified an Uptrend for Charles River Laboratories (NYSE:CRL) on December 14th, 2016 at $76.09. In approximately 6 months, Charles River Laboratories has returned 23.45% as of today's recent...

CRL : 101.16 (+0.06%)
CRL Crosses Above Average Analyst Target

In recent trading, shares of Charles River Laboratories International Inc. have crossed above the average analyst 12-month target price of $93.77, changing hands for $95.19/share.

CRL : 101.16 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Charles River Laboratories is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader inproviding the animal research models required in research and development for new drugs,...

See More

Support & Resistance

2nd Resistance Point 102.45
1st Resistance Point 101.80
Last Price 101.16
1st Support Level 100.54
2nd Support Level 99.93

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.